Retinol-Binding Protein 4 Induces Hepatic Mitochondrial Dysfunction and Promotes Hepatic Steatosis

    loading  Checking for direct PDF access through Ovid


Context and Objective:

Elevated serum retinol-binding protein 4 (RBP4) has been implicated in insulin resistant and nonalcoholic fatty liver disease (NAFLD) subjects; however, the molecular mechanism of RBP4 in NAFLD remains obscure.

Design and Participants:

Hepatic RBP4 mRNA level and its association with lipid accumulation were examined in NAFLD patients and mouse model. Furthermore, human RBP4 overexpressing (RBP4-Tg) mice were metabolically phenotyped after either a regular chow or high-fat diet.


RBP4 mRNA was aberrantly elevated in NAFLD models and positively associated with increased hepatic triglyceride accumulation. Compared with their wild-type littermates, RBP4-Tg mice fed regular chow had increased hepatic lipid accumulation associated with cellular ballooning and inflammatory changes, which was exacerbated when challenged with high-fat diet. The acceleration of NAFLD in RBP4-Tg mice was mainly attributed to reduced mitochondrial content and impaired mitochondrial fatty acid β-oxidation. RBP4 overexpression promoted the acetylation of long-chain acyl-coenzyme A dehydrogenase through inhibiting the expression and activity of NAD-dependent deacetylase sirtuin-3 and significantly hampered the binding of long-chain acyl-coenzyme A dehydrogenase and NAD-dependent deacetylase sirtuin-3. Moreover, RBP4-induced mitochondrial dysfunction preceded the deterioration of lipid metabolism.


These results have unraveled a novel role of RBP4 in hepatic mitochondrial dysfunction and steatosis and suggest that RBP4 might be a potential target for the early prevention of NAFLD.

Related Topics

    loading  Loading Related Articles